Inhibition of Allogeneic and Autologous T Cell Proliferation by Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients
Background. In ankylosing spondylitis (AS), accompanied by chronic inflammation, T cell expansion plays a pathogenic role; the immunoregulatory properties of bone marrow-derived mesenchymal stem cells (BM-MSCs) are impaired, while functional characteristics of their adipose tissue-derived counterpar...
Main Authors: | Ewa Kuca-Warnawin, Magdalena Plebańczyk, Krzysztof Bonek, Ewa Kontny |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2021/6637328 |
Similar Items
-
Modulatory Impact of Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients on T Helper Cell Differentiation
by: Ewa Kuca-Warnawin, et al.
Published: (2021-01-01) -
Modulation of T-Cell Activation Markers Expression by the Adipose Tissue–Derived Mesenchymal Stem Cells of Patients with Rheumatic Diseases
by: Ewa Kuca-Warnawin, et al.
Published: (2020-09-01) -
Adiponectin Isoforms and Leptin Impact on Rheumatoid Adipose Mesenchymal Stem Cells Function
by: Urszula Skalska, et al.
Published: (2016-01-01) -
Management of ankylosing spondylitis with infliximab
by: Éric Toussirot, et al.
Published: (2009-06-01) -
Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach
by: Kamal Abdolmohammadi, et al.
Published: (2019-01-01)